135 research outputs found
Spanish study of anticoagulation in haemodialysis
This study's objectives were to determine which anticoagulation
methods are commonly used in patients who are undergoing haemodialysis (HD) in
Spain, on what criteria do they depend, and the consequences arising from their
use. MATERIAL AND METHOD: Ours was a cross-sectional study based on two types of
surveys: a "HD Centre Survey" and a "Patient Survey". The first survey was
answered by 87 adult HD units serving a total of 6093 patients, as well as 2
paediatric units. Among these units, 48.3% were part of the public health system
and the remaining 51.7% units were part of the private health system. The patient
survey analysed 758 patients who were chosen at random from among the
aforementioned 78 HD units. RESULTs: A) HD Centre Survey: The majority of adult
HD units (n=61, 70.2%) used both kinds of heparin, 19 of them (21.8%) only used
LMWH and 7 of them (8%) only used UFH. The most frequently applied criteria for
the use of LMWH were medical indications (83.3% of HD units) and ease of
administration (29.5%). The most frequently used methods for adjusting the dosage
were clotting of the circuit (88.2% of units), bleeding of the vascular access
after disconnection (75.3%), and patient weight (57.6%). B) Patient Survey: The
distribution of the types of heparin used was: UFH: 44.1%, LMWH: 51.5%, and
dialysis without heparin in 4.4% of patients. LMWH was more frequently used in
public medical centres (64.2% of patients) than in private medical centres
(46.1%) (P<.001). LMWH was more frequently used in on-line haemodiafiltration
(HF) than in high-flux HD (P<.001). Antiplatelet agents were given to 45.5% of
patients, oral anticoagulants to 18.4% of patients, and both to 5% of patients.
Additionally, 4.4% of patients had suffered bleeding complications during the
previous week, and 1.9% of patients suffered thrombotic complications. Bleeding
complications were more frequent in patients with oral anticoagulants (P=.001),
although there was no association between the type of heparin and the occurrence
of bleeding or thrombotic complications. CONCLUSIONS: We are able to conclude
that there is a great amount of disparity in the criteria used for the medical
prescription of anticoagulation in HD. It is advisable that each HD unit revise
their own results as well as those from other centres, and possibly to create an
Anticoagulation Guide in Haemodialysis
Production of short-chain fatty acids (SCFAs) as chemicals or substrates for microbes to obtain biochemicals
Carboxylic acids have become interesting platform molecules in the last years due to their versatility to act as carbon sources for different microorganisms or as precursors for the chemical industry. Among carboxylic acids, short-chain fatty acids (SCFAs) such as acetic, propionic, butyric, valeric, and caproic acids can be biotechnologically produced in an anaerobic fermentation process from lignocellulose or other organic wastes of agricultural, industrial, or municipal origin. The biosynthesis of SCFAs is advantageous compared to chemical synthesis, since the latter relies on fossil-derived raw materials, expensive and toxic catalysts and harsh process conditions. This review article gives an overview on biosynthesis of SCFAs from complex waste products. Different applications of SCFAs are explored and how these acids can be considered as a source of bioproducts, aiming at the development of a circular economy. The use of SCFAs as platform molecules requires adequate concentration and separation processes that are also addressed in this review. Various microorganisms such as bacteria or oleaginous yeasts can efficiently use SCFA mixtures derived from anaerobic fermentation, an attribute that can be exploited in microbial electrolytic cells or to produce biopolymers such as microbial oils or polyhydroxyalkanoates. Promising technologies for the microbial conversion of SCFAs into bioproducts are outlined with recent examples, highlighting SCFAs as interesting platform molecules for the development of future bioeconomy
Dynamic Pressure Pain Hypersensitivity as Assessed by Roller Pressure Algometry in Episodic Cluster Headache
Are Major Repeater Patients Addicted to Suicidal Behavior?
The literature provides support for the hypothesis that some major repeaters (individuals with \u3e=5 lifetime suicide attempts) are addicted to suicidal behavior (SB). This study explores whether major repeaters are addicted to SB or not using 7 criteria: tolerance (Criterion 1), withdrawal (Criterion 2), loss of control (Criterion 3), problems in quitting/cutting down (Criterion 4), much time spent using (Criterion 5), substantial reduction in activities (Criterion 6), and adverse physiological/physical consequences (Criterion 7). Total dependence on SB was indicated by the presence of 3 or more of the 7 criteria in the last 12 months. This cross-sectional study at Puerta de Hierro University Hospital (Madrid, Spain) recruited 118 suicide attempters including 8 major repeaters (7%, 8/118), who were all females. The association between each SB addiction criterion, physiological dependence and total dependence with major repeater status was tested for significance and for effect size with odds ratios (ORs) and their 95% confidence intervals. As hypothesized, major repeaters met significantly higher frequency of criteria for total dependence on SB, OR=62.9 (6.4-615). A backward stepwise logistic regression model was used to provide an OR between major repeater status and total dependence status corrected by confounding variables. Age, panic disorder without agoraphobia, borderline personality disorder, history of psychiatric inpatient admission, and total dependence on SB were introduced as independent variables with major repeater status as the dependent variable. The model selected total dependence and age as the remaining significant variables in the last step. Accordingly, major repeaters appear to be addicted to SB
Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells
Recessive dystrophic epidermolysis bullosa is a severe skin fragility disease caused by loss of functional type VII collagen at the dermal-epidermal junction. A frameshift mutation in exon 80 of COL7A1 gene, c.6527insC, is highly prevalent in the Spanish patient population. We have implemented geneediting strategies for COL7A1 frame restoration by NHEJ-induced indels in epidermal stem cells from patients carrying this mutation. TALEN nucleases designed to cut within the COL7A1 exon 80 sequence were delivered to primary patient keratinocyte cultures by non-integrating viral vectors. After genotyping a large collection of vector-transduced patient keratinocyte clones with high proliferative potential, we identified a significant percentage of clones with COL7A1 reading frame recovery and Collagen VII protein expression. Skin equivalents generated with cells from a clone lacking exon 80 entirely were able to regenerate phenotypically normal human skin upon their grafting onto immunodeficient mice. These patientderived human skin grafts showed Collagen VII deposition at the basement membrane zone, formation of anchoring fibrils, and structural integrity when analyzed 12 weeks after grafting. Our data provide a proof-of-principle for recessive dystrophic epidermolysis bullosa treatment through ex vivo gene editing based on removal of pathogenic mutationcontaining, functionally expendable COL7A1 exons in patient epidermal stem cells.The study was mainly supported by DEBRA International—funded by
DEBRA Austria (grant termed as Larcher 1). Additional funds come
from Spanish grants SAF2013-43475-R and SAF2017-86810-R from
the Ministry of Economy and Competitiveness and PI14/00931 and
PI17/01747 from the Instituto de Salud Carlos III, all of them
co-funded with European Regional Development Funds (ERDF)
Summary report of MINSIS workshop in Madrid
Recent developments on tau detection technologies and the construction of
high intensity neutrino beams open the possibility of a high precision search
for non-standard {\mu} - {\tau} flavour transition with neutrinos at short
distances. The MINSIS - Main Injector Non-Standard Interaction Search- is a
proposal under discussion to realize such precision measurement. This document
contains the proceedings of the workshop which took place on 10-11 December
2009 in Madrid to discuss both the physics reach as well as the experimental
requirements for this proposal.Comment: Proceedings of the MINSIS Workshop, Dec 10-11, 2009 in Madrid. 15
pages late
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis.
Neutrophil extracellular traps (NETs) induce a procoagulant response linking inflammation and thrombosis. Low levels of miR-146a, a brake of inflammatory response, are involved in higher risk for cardiovascular events, but the mechanisms explaining how miR-146a exerts its function remain largely undefined. The aim of this study was to explore the impact of miR-146a deficiency in NETosis both, in sterile and non-sterile models in vivo, and to inquire into the underlying mechanism. Two models of inflammation were performed: 1) Ldlr-/- mice transplanted with bone marrow from miR-146a-/- or wild type (WT) were fed high-fat diet, generating an atherosclerosis model; and 2) an acute inflammation model was generated by injecting lipopolysaccharide (LPS) (1 mg/Kg) into miR-146a-/- and WT mice. miR-146a deficiency increased NETosis in both models. Accordingly, miR-146a-/- mice showed significant reduced carotid occlusion time and elevated levels of NETs in thrombi following FeCl3-induced thrombosis. Infusion of DNAse I abolished arterial thrombosis in WT and miR-146a-/- mice. Interestingly, miR-146a deficient mice have aged, hyperreactive and pro-inflammatory neutrophils in circulation that are more prone to form NETs independently of the stimulus. Furthermore, we demonstrated that community acquired pneumonia (CAP) patients with reduced miR-146a levels associated with the T variant of the functional rs2431697, presented an increased risk for cardiovascular events due in part to an increased generation of NETs.This work was supported by research grants from Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional “Investing in your future” (PI17/00051 y PI17/01421) (PFIS18/0045: A.M. de los Reyes-García) (CD18/00044: S. Águila), and Fundación Séneca (19873/GERM/15). The CNIC is supported by the ISCIII, the Ministerio de Ciencia, Innovación y Universidades (MCIU), and the Fundación Pro CNIC, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). A.B. Arroyo has a research fellowship from Sociedad Española de Trombosis y Hemostasia (SETH). The MCIU supported A.dM. (predoctoral contract BES-2014-067791).S
- …